Breast cancer in men and women differ in levels of cancer-associated gene expression and the relative risk of recurrence after initially successful treatment. Some men have a higher risk than women, whereas others have a much lower risk.
Stanford’s Cancer Genetics Program helps assess families' hereditary cancer risks and guide patients to make informed choices about prevention and treatment.
According to Stanford pediatric oncologist Crystal Mackall, a pediatric oncologist with Stanford Children's Health, immunotherapy with CAR T cells is more precise, more specific and just as potent a treatment for leukemia as chemotherapy.
On the Future of Everything radio show, Stanford bioengineer Jennifer Cochran discusses her development of "tumor-targeting missiles" that deliver chemotherapy as "cargo" to more effectively kill cancer.
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
This Stanford Medicine study clarifies the underlying biology of high-grade serous ovarian cancer and could help lead to future therapies.
Douglas Lowy, deputy director of the National Cancer Institute, recently spoke at Stanford Medicine.
Stanford researchers led work on a possible cancer vaccine that involves injecting two immune-stimulating agents directly into solid tumors.
Six groups of researchers collaborated to study the effect of advances in breast cancer screening and treatment on mortality rates.
A conversation with Becky Hall and the short film she made about shaving her head before chemotherapy.
Loss of taste sensation occurs in about 85 percent of cancer patients receiving chemotherapy. A new Stanford study explored the problem.
Three-time cancer survivor Fred Reiss uses comedy to share his experience with the disease.
As a parent, some stories are more difficult to write than others. My recent Stanford Medicine magazine article about kids with leukemia is an example. …